Brief: India's Dr. Lal Pathlabs Q1 Consol Net Profit Beats Estimates
27/07/2023 10:03
July 27 (Reuters) - Dr. Lal PathLabs Ltd DLPA.NS :
* Q1 CONSOL NET PROFIT 826 MILLION RUPEES; REFINITIV IBES
EST.
712.5 MILLION RUPEES
* Q1 CONSOL REVENUE FROM OPERATIONS 5.41 BILLION RUPEES
* YEAR AGO Q1 NET PROFIT 577 MILLION RUPEES, REVENUE 5.03
BILLION
RUPEES
* INTERIM DIVIDEND OF 6 RUPEES PER SHR
Source text for Eikon: ID:nNSE8zgkKz
Further company coverage: DLPA.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dr. Lal PathLabs
See all newsBrief: Lal Pathlabs Says Unit Acquired Remaining 30% Equity Stake In Centrapath Labs Private Limited
India's Dr Lal PathLabs rises as Axis Securities initiates with 'buy'
India's Dr Lal PathLabs rises; analysts back SN Genelab deal
Brief: Lal Pathlabs Says Subsidiary Incorporated Dr Lal Pathlabs Indomed In Tashkent, Uzbekistan
India's Dr Lal PathLabs jumps to 4-year high after quarterly profit rise